济南冠状沟长红点 痒-【济南附一医院】,济南附一医院,济南中药治阳痿早泄,济南前列腺增生的症状,济南包茎长时间短怎么办,济南阴茎长红疙瘩看什么科,济南早泄自治,济南男人阴囊炎
济南冠状沟长红点 痒济南早泄 敏感 治疗,济南看男性哪家医院好,济南包皮为什么老破,济南会阳痿怎么办,济南包皮手术要多少价格,济南切包茎办法,济南治疗早泄大约的价格是多少
WASHINGTON, Dec. 21 (Xinhua) -- NASA's Dawn spacecraft has sent around 10,000 pictures of the giant asteroid Vesta back to Earth for the first time since its launch in 2007, the U.S. space agency announced Wednesday.The images were taken from an average altitude of 209 km, the closest the spacecraft can get.From the images, scientists could see Vesta's stippled and lumpy surface in great detail, and its many small craters, grooves, and lineaments. The fine scale of the images highlights small outcrops of bright and dark material.With these new discoveries, scientists believe that studying Vesta can help decode the early history of the solar system.Dawn will maintain its low-altitude orbit for another 10 weeks before moving to a higher orbit for another round of photo-taking.Launched in 2007, the 446 million U.S. dollar project aims at studying the chemical composition of Vesta's surface and probing its interior structure.Dawn will leave Vesta in July next year and arrive at the dwarf planet Ceres in February 2015.
WELLINGTON, Oct. 26 (Xinhua) -- New Zealand's geothermal scientists will be collaborating with the world's leading geothermal researchers after the country joins an elite international group next month.New Zealand would be admitted to the International Partnership for Geothermal Technology (IPGT) in Melbourne, Australia, on Nov. 16, Science and Innovation Minister Wayne Mapp announced Wednesday."Geothermal energy is one of our most important renewable energy resources with huge potential for growth," said Mapp."This recognition of our geothermal research programs will allow our scientists to collaborate with an elite group of researchers in the United States, Australia, Switzerland and Iceland."Scientists from New Zealand research organizations were committed to finding new ways to harness the country's extensive geothermal fields, said Mapp."Innovation and clean energy is a big part of enabling New Zealand to grow the economy," said Mapp."This new international partnership will help keep us at the forefront of technology developments such as enhanced geothermal systems."Established in 2008, the IPGT seeks to develop advanced, cost- effective geothermal energy technologies through international research co-operation.New Zealand's geothermal electricity generation rose by 21 percent last year and accounted for 13 percent of total electricity generation, its highest recorded level.The government is aiming to expand geothermal energy with three large geothermal projects in the pipeline by 2020.The country's biggest geothermal project is to be Contact Energy's 250-megawatt Tauhara II geothermal project.The project, being developed northeast of the central North Island town of Taupo, is expected to produce enough electricity to meet the needs of around 270,000 homes when it becomes fully operational in 2015.
BEIJING, Oct. 12 (Xinhuanet) -- Study found that women who took multivitamins may actually be at risk, media reports on Wednsday.Women who took the dietary supplements vitamin B6, folic acid, magnesium, zinc, copper, iron and multivitamins had a higher risk of death than women who did not.The new study, published in the Archives of Internal Medicine, examined more than 38,000 women aged 55 and older who took part in the Iowa Women's Health Study, which started in the mid 1980s. Researchers found the vitamins did nothing to reduce the risk of death and that most supplements have no positive effect on women's health.The study did not distinguish if the women in the study took the vitamins to fight diseases or to maintain health.Vitamin experts say the best way to make sure you are getting all necessary vitamins is to eat a well-balanced diet. The vitamins people take do not depend on personal preference.
OTTAWA, Oct. 3 (Xinhua) -- Many friends and colleagues of Canadian scientist Ralph Steinman reacted with shock when they learned on Monday that Steinman won the Nobel Prize for Medicine and Physiology three days after he died.Since 1974, Nobel Prizes are no longer awarded posthumously, but the Nobel Prize committee said that it had made its choice before Steinman's death.Many of Steinman's friends and colleagues said that they learned of Steinman's death at the same time that they learned of his Nobel Prize, which was awarded for a discovery Steinman made in 1973.Steinman, 68, discovered dendritic cells, which help regulate adaptive immunity, which purges invading microorganisms from the body. Dendritic cells activate T cells, which "remember" the DNA sequence of invading organisms and protect the body from later infections from the same disease."Their work has opened up new avenues for the development of prevention and therapy against infections, cancer and inflammatory disease," the citation said.Monday, the Nobel Committee defended its decision to award the prize to Steinman. "The decision to award the Nobel Prize to Ralph Steinman was made in good faith, based on the assumption that the Nobel Laureate was alive," the foundation said in a statement."The Nobel Foundation thus believes that what has occurred is more reminiscent of the example in the statutes concerning a person who has been named as a Nobel Laureate and has died before the actual Nobel Prize Award Ceremony."It is still unclear who will pick up Steinman's prize at the award ceremony later this year.Steinman, a cell biologist at Rockefeller University in New York City, died of pancreatic cancer on Friday. For more than four years, he had used his own immune therapy discoveries to extend his life."The news is bittersweet, as we also learned this morning from Ralph's family that he passed a few days ago," Rockefeller University President Marc Tessier-Lavigne said in a statement."We are all so touched that our father's many years of hard work are being recognized with a Nobel Prize," Steinman's daughter, Alexis, said in the statement. "He devoted his life to his work and his family, and he would be truly honored."Steinman's heirs will share the 1.5-million U.S. dollar prize with American genetics professor Bruce Beutler and French scientist Jules Hoffmann.Dr. Beutler is professor of genetics and immunology at The Scripps Research Institute in La Jolla, California. Dr. Hoffmann headed a research laboratory in Strasbourg, France, between 1974 and 2009 and served as president of the French National Academy of Sciences between 2007 and 2008."Ralph worked right up until last week," said Michel Nussenzweig, a collaborator of Steinman's at Rockefeller University. "His dream was to use his discovery to cure cancer and infectious diseases like HIV and tuberculosis. It's a dream that's pretty close."Steinman was born in 1943 in Montreal, Canada's second largest city, and studied chemistry and biology at McGill University in his hometown before receiving an MD from Harvard Medical School in Boston in 1968. He joined Rockefeller University in 1970 as a postdoctoral fellow."He was diagnosed with pancreatic cancer four years ago, and his life was extended using a dendritic-cell based immunotherapy of his own design," the university said in a statement.In a statement, Canadian Prime Minister Stephen Harper lauded the three winners of the Nobel for medicine and called the award " a fitting final tribute" to Steinman's life's work."Dr. Steinman shall be honored for all time with this achievement," Harper said. "Canadians will mourn his loss."